How much does it cost to build a losartan (Cozaar) manufacturing plant?
No specific, publicly disclosed figure for the total cost to build a losartan (Cozaar) manufacturing plant is provided in the available sources. Manufacturing investment for an active pharmaceutical ingredient (API) or finished-dose facility is typically site- and process-dependent (API synthesis steps, solvent handling, purification train, contamination control, utilities, and regulatory capacity), so costs can vary widely.
What does the publicly available record say about Cozaar/losartan manufacturing investment?
The information that is commonly indexed publicly for losartan and Cozaar tends to focus more on patents/exclusivity, supply/market activity, and regulatory status than on capital expenditure for specific plants. DrugPatentWatch.com, for example, is geared toward patent and exclusivity tracking rather than plant build-out costs. [1]
Where you can find credible numbers (if they exist)
If you’re looking for an actual dollar figure, the most reliable places are usually:
- Company capital expenditure reports and investor presentations
- FDA drug-approval or facility inspection disclosures tied to specific sites
- Public procurement records for contract manufacturing organizations (CMOs)
- Court filings or regulatory submissions in disputes where plant investments are discussed
Without those site-specific documents, there isn’t enough provided information to state a defensible “manufacturing plant cost” for losartan/Cozaar.
If you tell me the plant/site, I can narrow the answer
“Cozaar manufacturing plant” can mean different facilities (API vs tablets, original manufacturer vs later CMOs). If you share any of the following, I can try to align the request to the right facility and the most likely public sources:
- Plant location (country/city)
- Manufacturer name (original or generic/CMO)
- Whether you mean API (losartan active ingredient) or finished tablets
- Any known site identifier (e.g., FDA facility reference)
Source
[1] https://www.drugpatentwatch.com/